Two landmark, randomised trials (48, 49) demonstrated a reduction in birthweight and large‐for‐gestational‐age infants in women with GDM who received treatment (combination of dietary advice, self-monitoring of blood glucose and insulin therapy) compared with women with GDM who were not treated. The gene discussed is INS; the disease is gestational diabetes.